Neil Carrigan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Neil Carrigan has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Peter Gardner
Wolfson Centre for Applied Health Research, Bradford, UK
4 shared publications - Peter Knapp
School of Healthcare, University of Leeds, Leeds, UK
3 shared publications A. Woolard
2 shared publicationsD. K. Raynor
School of Healthcare, University of Leeds, Leeds, UK
2 shared publicationsJ. Julien
2 shared publicationsJohn Maule
Leeds University Business School, University of Leeds, LS2 9JT
2 shared publications
Latest Publications
- Open Access
Sleep quality, mental health and circadian rhythms during COVID lockdown – Results from the SleepQuest Study
Behavioural responses to COVID-19 lockdown will define the long-term impact of psychological stressors on sleep and brain health. Here we tease apart factors that help protect against sleep disturbance. We capitalise on the unique restrictions during COVID-19 to understand how time of day of daylight exposure and outside exercise interact with chronotype and sleep quality. 3474 people from the UK (median age 62, range 18-91) completed our online ‘SleepQuest’ Study between 29th April and 13th May 2020 – a set of validated questionnaires probing sleep quality, depression, anxiety and attitudes to sleep alongside bespoke questions on the effect of COVID-19 lockdown on sleep, time spent outside and exercising and self-help sleep measures. Significantly more people (n=1252) reported worsened than improved sleep (n=562) during lockdown (p<0.0001). Factors significantly associated with worsened sleep included low mood (p<0.001), anxiety (p<0.001) and suspected, proven or at risk of COVID-19 symptoms (all p<0.03). Sleep improvement was related to the increased length of time spent outside (P<0.01). Older people’s sleep quality was less affected than younger people by COVID lockdown (p<0.001). Better sleep quality was associated with going outside and exercising earlier, rather than later, in the day. However, the benefit of being outside early is driven by improved sleep in ‘owl’ (p=0.0002) and not ‘lark’ (p=0.27) chronotype, whereas, the benefit of early exercise (inside or outside) did not depend on chronotype. Defining the interaction between chronotype, mental health and behaviour will be critical for targeted lifestyle adaptations to protect brain health through current and future crises.
Open AccessSleep quality, mental health and circadian rhythms during COVID lockdown – Results from the SleepQuest Study
Behavioural responses to COVID-19 lockdown will define the long-term impact of psychological stressors on sleep and brain health. Here we tease apart factors that help protect against sleep disturbance. We capitalise on the unique restrictions during COVID-19 to understand how time of day of daylight exposure and outside exercise interact with chronotype and sleep quality. 3474 people from the UK (median age 62, range 18-91) completed our online ‘SleepQuest’ Study between 29th April and 13th May 2020 – a set of validated questionnaires probing sleep quality, depression, anxiety and attitudes to sleep alongside bespoke questions on the effect of COVID-19 lockdown on sleep, time spent outside and exercising and self-help sleep measures. Significantly more people (n=1252) reported worsened than improved sleep (n=562) during lockdown (p<0.0001). Factors significantly associated with worsened sleep included low mood (p<0.001), anxiety (p<0.001) and suspected, proven or at risk of COVID-19 symptoms (all p<0.03). Sleep improvement was related to the increased length of time spent outside (P<0.01). Older people’s sleep quality was less affected than younger people by COVID lockdown (p<0.001). Better sleep quality was associated with going outside and exercising earlier, rather than later, in the day. However, the benefit of being outside early is driven by improved sleep in ‘owl’ (p=0.0002) and not ‘lark’ (p=0.27) chronotype, whereas, the benefit of early exercise (inside or outside) did not depend on chronotype. Defining the interaction between chronotype, mental health and behaviour will be critical for targeted lifestyle adaptations to protect brain health through current and future crises.
- 9 October 2017
- Published by Cambridge University Press (CUP) in Behavioural and Cognitive Psychotherapy
- Vol. 46 (2) , 148-167
The Impact of Health Anxiety in Multiple Sclerosis: A Replication and Treatment Case Series
Background:Multiple sclerosis (MS) is commonly associated with psychological complications. Previous research by Hayter and colleagues (2016) found that in patients with MS, health anxiety (HA) can account for part of the variance in quality of life (QoL) independent of physical and cognitive impairment caused by the disease. MS patients with HA perceived their intact physical and cognitive performance as impaired relative to those without HA and attributed the impairment to MS. These misperceptions might be useful targets in the treatment of HA in MS using cognitive behaviour therapy (CBT).Aims:Study 1 sought to replicate the main findings from Hayter et al. (2016). Study 2 examined the impact of HA-focused CBT in a case series.Method:In Study 1, twenty participants with MS were screened for HA and assigned to either a high or low HA group. They completed assessments of cognitive and physical functioning before rating their performance on these tasks, followed by measures of QoL, mood and physical disability. Four participants in the high HA group subsequently received six sessions of CBT using a consecutive AB case series in Study 2.Results:Study 1 replicated the main findings from the earlier study. In Study 2, three of the four patients who received treatment showed substantial improvements in HA and mood and all showed improvement in QoL.Conclusion:Given the high rates of HA in MS patients and its impact on QoL, this case series suggests that a brief CBT intervention could significantly improve patients’ wellbeing.
- 9 October 2017
- Published by Cambridge University Press (CUP) in Behavioural and Cognitive Psychotherapy
- Vol. 46 (2) , 148-167
The Impact of Health Anxiety in Multiple Sclerosis: A Replication and Treatment Case Series
Background:Multiple sclerosis (MS) is commonly associated with psychological complications. Previous research by Hayter and colleagues (2016) found that in patients with MS, health anxiety (HA) can account for part of the variance in quality of life (QoL) independent of physical and cognitive impairment caused by the disease. MS patients with HA perceived their intact physical and cognitive performance as impaired relative to those without HA and attributed the impairment to MS. These misperceptions might be useful targets in the treatment of HA in MS using cognitive behaviour therapy (CBT).Aims:Study 1 sought to replicate the main findings from Hayter et al. (2016). Study 2 examined the impact of HA-focused CBT in a case series.Method:In Study 1, twenty participants with MS were screened for HA and assigned to either a high or low HA group. They completed assessments of cognitive and physical functioning before rating their performance on these tasks, followed by measures of QoL, mood and physical disability. Four participants in the high HA group subsequently received six sessions of CBT using a consecutive AB case series in Study 2.Results:Study 1 replicated the main findings from the earlier study. In Study 2, three of the four patients who received treatment showed substantial improvements in HA and mood and all showed improvement in QoL.Conclusion:Given the high rates of HA in MS patients and its impact on QoL, this case series suggests that a brief CBT intervention could significantly improve patients’ wellbeing.
- 24 October 2016
- Published by SAGE Publications in Clinical Case Studies
- Vol. 16 (2) , 115-131
Cognitive Behavioral Therapy for Insomnia (CBT-I) for an Adult With Multiple Sclerosis
Poor sleep quality is more common in patients with multiple sclerosis (MS) than in the general population and is associated with greater disease severity, pain, and poorer quality of life. However, despite its prevalence, sleep problems frequently go untreated or are managed with sleep medication which can be ineffective in the long term and is associated with daytime fatigue and tolerance. In this case study, an individual with MS who had been experiencing sleep problems and had reported dependency on sleep medication was treated with a Cognitive Behavioral Therapy for Insomnia (CBT-I) program over the course of 3 months, with the goal of improving sleep quality while reducing sleep medication. By the end of the treatment, subjective sleep quality had improved, as measured by the Pittsburgh Sleep Quality Index and a sleep diary. Over the course of the treatment, the patient reduced his sleep medication to nil until he was sleeping with no sleep disturbance. Self-reported sleep measures at follow-up showed that these improvements in sleep quality had remained. In addition, scores on self-reported measures of life satisfaction, impact of MS on physical and psychological functioning, and anxiety and depression scores all showed improvements from assessment to follow-up. This case study illustrates a potential non-pharmaceutical treatment option for sleep problems for individuals with MS which is evidence-based in the general population and other comorbid conditions.
- 24 October 2016
- Published by SAGE Publications in Clinical Case Studies
- Vol. 16 (2) , 115-131
Cognitive Behavioral Therapy for Insomnia (CBT-I) for an Adult With Multiple Sclerosis
Poor sleep quality is more common in patients with multiple sclerosis (MS) than in the general population and is associated with greater disease severity, pain, and poorer quality of life. However, despite its prevalence, sleep problems frequently go untreated or are managed with sleep medication which can be ineffective in the long term and is associated with daytime fatigue and tolerance. In this case study, an individual with MS who had been experiencing sleep problems and had reported dependency on sleep medication was treated with a Cognitive Behavioral Therapy for Insomnia (CBT-I) program over the course of 3 months, with the goal of improving sleep quality while reducing sleep medication. By the end of the treatment, subjective sleep quality had improved, as measured by the Pittsburgh Sleep Quality Index and a sleep diary. Over the course of the treatment, the patient reduced his sleep medication to nil until he was sleeping with no sleep disturbance. Self-reported sleep measures at follow-up showed that these improvements in sleep quality had remained. In addition, scores on self-reported measures of life satisfaction, impact of MS on physical and psychological functioning, and anxiety and depression scores all showed improvements from assessment to follow-up. This case study illustrates a potential non-pharmaceutical treatment option for sleep problems for individuals with MS which is evidence-based in the general population and other comorbid conditions.
- 12 February 2016
- Published by Wiley in Journal of Applied Research in Intellectual Disabilities
- Vol. 30 (2) , 326-335
Cognitive Behaviour Therapy for Post‐Traumatic Stress Disorder in a person with an Autism Spectrum Condition and Intellectual Disability: A Case Study
Background: One of the difficulties in assessing and treating PTSD in people with intellectual disability is that it may not present with the typical symptoms associated with the disorder. This may be why there is a dearth of literature on the treatment of PTSD using cognitive behavioural approaches for people with intellectual disability (e.g. Ehlers et al. Behav Res Ther, 43, 2005, 413–431). This paper reports the treatment for PTSD in a young man diagnosed with autism and a mild intellectual disability.Method: Treatment involved 12 sessions of cognitive therapy for PTSD using the approach developed by Ehlers et al.Results: There was an overall reduction in symptoms and a self‐reported elevation in mood. With careful questioning, adaptation of language and elucidation of concepts, the patient was able to fully engage in therapy.Discussion: This case suggests that cognitive approaches to treating PTSD can be successful in people with intellectual disability and autism.
- 12 February 2016
- Published by Wiley in Journal of Applied Research in Intellectual Disabilities
- Vol. 30 (2) , 326-335
Cognitive Behaviour Therapy for Post‐Traumatic Stress Disorder in a person with an Autism Spectrum Condition and Intellectual Disability: A Case Study
Background: One of the difficulties in assessing and treating PTSD in people with intellectual disability is that it may not present with the typical symptoms associated with the disorder. This may be why there is a dearth of literature on the treatment of PTSD using cognitive behavioural approaches for people with intellectual disability (e.g. Ehlers et al. Behav Res Ther, 43, 2005, 413–431). This paper reports the treatment for PTSD in a young man diagnosed with autism and a mild intellectual disability.Method: Treatment involved 12 sessions of cognitive therapy for PTSD using the approach developed by Ehlers et al.Results: There was an overall reduction in symptoms and a self‐reported elevation in mood. With careful questioning, adaptation of language and elucidation of concepts, the patient was able to fully engage in therapy.Discussion: This case suggests that cognitive approaches to treating PTSD can be successful in people with intellectual disability and autism.
- Open Access
- 29 January 2010
- Published by Open Publishing Association in Electronic Proceedings in Theoretical Computer Science
- Vol. 16, 51-63
A Framework to Manage the Complex Organisation of Collaborating: Its Application to Autonomous Systems
In this paper we present an analysis of the complexities of large group collaboration and its application to develop detailed requirements for collaboration schema for Autonomous Systems (AS). These requirements flow from our development of a framework for collaboration that provides a basis for designing, supporting and managing complex collaborative systems that can be applied and tested in various real world settings. We present the concepts of "collaborative flow" and "working as one" as descriptive expressions of what good collaborative teamwork can be in such scenarios. The paper considers the application of the framework within different scenarios and discuses the utility of the framework in modelling and supporting collaboration in complex organisational structures
- 29 January 2010
- Published by Open Publishing Association in Electronic Proceedings in Theoretical Computer Science
- Vol. 16, 51-63
Open AccessA Framework to Manage the Complex Organisation of Collaborating: Its Application to Autonomous Systems
In this paper we present an analysis of the complexities of large group collaboration and its application to develop detailed requirements for collaboration schema for Autonomous Systems (AS). These requirements flow from our development of a framework for collaboration that provides a basis for designing, supporting and managing complex collaborative systems that can be applied and tested in various real world settings. We present the concepts of "collaborative flow" and "working as one" as descriptive expressions of what good collaborative teamwork can be in such scenarios. The paper considers the application of the framework within different scenarios and discuses the utility of the framework in modelling and supporting collaboration in complex organisational structures
- 1 January 2010
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 623-628
Collaboration and conflict: A framework for large-scale collaborations
In this poster paper we present an analysis of the complexities of large group collaboration that provides a basis for designing, supporting and managing complex collaborative systems that can be applied in various real world settings. We introduce the concepts of “collaborative flow” and “working as one” as descriptive expressions of successful collaborations. The paper then develops a large-scale collaboration framework and considers the application of this framework in different domains and discusses its utility in modelling and supporting collaboration in complex social structures.
- 1 January 2010
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 623-628
Collaboration and conflict: A framework for large-scale collaborations
In this poster paper we present an analysis of the complexities of large group collaboration that provides a basis for designing, supporting and managing complex collaborative systems that can be applied in various real world settings. We introduce the concepts of “collaborative flow” and “working as one” as descriptive expressions of successful collaborations. The paper then develops a large-scale collaboration framework and considers the application of this framework in different domains and discusses its utility in modelling and supporting collaboration in complex social structures.
- 1 October 2009
- Published by Springer Nature in Drug Safety
- Vol. 32 (10) , 837-849
Communicating the Risk of Side Effects to Patients
Background: All licensed medicines in the European Union must be provided with a Patient Information Leaflet that includes a list of all known side effects. Among patients who read the leaflet, the side effects section is the most often read. A UK government regulatory publication recommends providing medicine side effect risk information in a combined format, using verbal descriptors accompanied by numerical information. Objectives: This study, with users of an existing popular patient information website, investigates the effectiveness of presenting medicine side effect risk information in different forms. Design: Participants were randomly allocated to one of the three formats for representing risk information (verbal descriptors, e.g. ‘common’; absolute frequencies, e.g. ‘less than 1 in 10 people’; and a combination of verbal descriptors and frequency bands, e.g. ‘common (affects less than 1 in 10 people)’. Methods: Participants (n= 187) were recruited from users of the Cancer Research UK patient information website. They were asked to imagine that they had to take a cancer treatment (tamoxifen), estimate the risks of four side effects occurring, and complete Likert scales relating to their satisfaction with the information supplied and perceived likelihood of various outcomes. Results: Those in the absolute frequency format demonstrated greater accuracy in estimating the likelihood of having two of four side effects than the other two formats. They were also more accurate at estimating the likelihood of themselves or the average person having any side effect from taking tamoxifen. Participants in the absolute frequency format rated the risk to health from tamoxifen as lower than those in the other two formats, were more satisfied with the information they received than those in the verbal format, and felt there would be less impact of the information on tamoxifen use than those in the combined format. Conclusions: These findings fail to confirm that the recommended use of combined descriptors for medicine side effects is unequivocally superior to absolute frequency alone. They also add weight to the growing body of research highlighting the deficiencies in using verbal descriptors for conveying side effect risk, and the strength of using absolute frequency descriptors.
- 1 October 2009
- Published by Springer Nature in Drug Safety
- Vol. 32 (10) , 837-849
Communicating the Risk of Side Effects to Patients
Background: All licensed medicines in the European Union must be provided with a Patient Information Leaflet that includes a list of all known side effects. Among patients who read the leaflet, the side effects section is the most often read. A UK government regulatory publication recommends providing medicine side effect risk information in a combined format, using verbal descriptors accompanied by numerical information. Objectives: This study, with users of an existing popular patient information website, investigates the effectiveness of presenting medicine side effect risk information in different forms. Design: Participants were randomly allocated to one of the three formats for representing risk information (verbal descriptors, e.g. ‘common’; absolute frequencies, e.g. ‘less than 1 in 10 people’; and a combination of verbal descriptors and frequency bands, e.g. ‘common (affects less than 1 in 10 people)’. Methods: Participants (n= 187) were recruited from users of the Cancer Research UK patient information website. They were asked to imagine that they had to take a cancer treatment (tamoxifen), estimate the risks of four side effects occurring, and complete Likert scales relating to their satisfaction with the information supplied and perceived likelihood of various outcomes. Results: Those in the absolute frequency format demonstrated greater accuracy in estimating the likelihood of having two of four side effects than the other two formats. They were also more accurate at estimating the likelihood of themselves or the average person having any side effect from taking tamoxifen. Participants in the absolute frequency format rated the risk to health from tamoxifen as lower than those in the other two formats, were more satisfied with the information they received than those in the verbal format, and felt there would be less impact of the information on tamoxifen use than those in the combined format. Conclusions: These findings fail to confirm that the recommended use of combined descriptors for medicine side effects is unequivocally superior to absolute frequency alone. They also add weight to the growing body of research highlighting the deficiencies in using verbal descriptors for conveying side effect risk, and the strength of using absolute frequency descriptors.
- 1 September 2009
- Published by Wiley in British Journal of Health Psychology
- Vol. 14 (3) , 579-594
Perceived risk of medicine side effects in users of a patient information website: A study of the use of verbal descriptors, percentages and natural frequencies
Objectives . Research into the provision of patient information has demonstrated that, under certain conditions, patients overestimate the risks of medicine side effects. Gigerenzer and Edwards (2004) argue that ‘natural frequencies’ are a less confusing way of expressing risk information. Two experiments with users of an existing high profile patient information website, investigate the effectiveness of presenting medicine side‐effect risk information in different forms. Design . In both experiments participants were randomly allocated to one of the three conditions for representing risk information (a form of ‘natural frequency’, percentages and verbal descriptors). Method . Participants were recruited from users of the Cancer Research UK patient information website (Cancer Help UK). In Experiment 1, participants ( N = 148) were asked to imagine that they had to take a chemotherapy drug (Taxol ® ) and were asked to estimate the risks of two side‐effects occurring. In Experiment 2 participants ( N = 137) estimated the risk for three different side‐effects occurring with the painkiller ibuprofen. Results . In both experiments, verbal descriptions led to significantly higher estimations of risk compared to the other two formats. There was some evidence that people given information as frequencies were more accurate in their estimates than those given percentage information. Conclusions . These findings provide partial support for the advantages of a form of ‘natural frequencies’ when presenting side‐effects to patients. They also add weight to the growing body of research highlighting the deficiencies in using verbal descriptions of side‐effect risk alone.
- 1 September 2009
- Published by Wiley in British Journal of Health Psychology
- Vol. 14 (3) , 579-594
Perceived risk of medicine side effects in users of a patient information website: A study of the use of verbal descriptors, percentages and natural frequencies
Objectives . Research into the provision of patient information has demonstrated that, under certain conditions, patients overestimate the risks of medicine side effects. Gigerenzer and Edwards (2004) argue that ‘natural frequencies’ are a less confusing way of expressing risk information. Two experiments with users of an existing high profile patient information website, investigate the effectiveness of presenting medicine side‐effect risk information in different forms. Design . In both experiments participants were randomly allocated to one of the three conditions for representing risk information (a form of ‘natural frequency’, percentages and verbal descriptors). Method . Participants were recruited from users of the Cancer Research UK patient information website (Cancer Help UK). In Experiment 1, participants ( N = 148) were asked to imagine that they had to take a chemotherapy drug (Taxol ® ) and were asked to estimate the risks of two side‐effects occurring. In Experiment 2 participants ( N = 137) estimated the risk for three different side‐effects occurring with the painkiller ibuprofen. Results . In both experiments, verbal descriptions led to significantly higher estimations of risk compared to the other two formats. There was some evidence that people given information as frequencies were more accurate in their estimates than those given percentage information. Conclusions . These findings provide partial support for the advantages of a form of ‘natural frequencies’ when presenting side‐effects to patients. They also add weight to the growing body of research highlighting the deficiencies in using verbal descriptions of side‐effect risk alone.
- 1 January 2008
- Published by Springer Nature in Drug Safety
- Vol. 31 (4) , 305-312
Adequacy of Patient Information on Adverse Effects
Background: One of the most important categories of information that patients want to know about the drug they are taking is the likelihood or probability of adverse effects. All patients should receive such information in the patient information leaflet that is supplied with all drugs. Anecdotal evidence suggests that most leaflets give little indication of the likelihood of adverse effects. The UK Medicines and Healthcare products Regulatory Agency (MHRA) suggests using a combination of words and numbers to convey this information. However, an EU guideline suggests using five verbal descriptors on a scale from common to rare, the use of which has been shown to lead to gross overestimation of the risk of adverse effects. Methods: We assessed the leaflets supplied with the 50 most frequently prescribed drugs in England, to determine the extent to which the likelihood of adverse effects was described, and whether it met the requirements of the EU guidance and/or best practice. We examined both the method used to describe the likelihood of adverse effects, and the format of this information in the leaflet. Results: Twenty of the 50 leaflets (40%) gave no indication of the likelihood of adverse effects occurring. Six (12%) used the recommended EU terms and a further 20 (40%) used a wide range of other verbal descriptors. Only four leaflets (8%) provided any form of numerical indication of risk. Over half (52%) presented long lists of adverse effects in paragraphs of continuous text. Conclusions: Patient need is not being met in terms of the provision of usable information about the likelihood of adverse effects. Most patients receive no information, whereas some are given verbal descriptors, both of which lead to overestimation of the risk. Very few of the patient information leaflets assessed used currently described best practice, i.e. to present verbal descriptions alongside numerical information in the form of natural frequencies, e.g. ‘rare (affects less than 1 in 1000 people)’.
- 1 January 2008
- Published by Springer Nature in Drug Safety
- Vol. 31 (4) , 305-312
Adequacy of Patient Information on Adverse Effects
Background: One of the most important categories of information that patients want to know about the drug they are taking is the likelihood or probability of adverse effects. All patients should receive such information in the patient information leaflet that is supplied with all drugs. Anecdotal evidence suggests that most leaflets give little indication of the likelihood of adverse effects. The UK Medicines and Healthcare products Regulatory Agency (MHRA) suggests using a combination of words and numbers to convey this information. However, an EU guideline suggests using five verbal descriptors on a scale from common to rare, the use of which has been shown to lead to gross overestimation of the risk of adverse effects. Methods: We assessed the leaflets supplied with the 50 most frequently prescribed drugs in England, to determine the extent to which the likelihood of adverse effects was described, and whether it met the requirements of the EU guidance and/or best practice. We examined both the method used to describe the likelihood of adverse effects, and the format of this information in the leaflet. Results: Twenty of the 50 leaflets (40%) gave no indication of the likelihood of adverse effects occurring. Six (12%) used the recommended EU terms and a further 20 (40%) used a wide range of other verbal descriptors. Only four leaflets (8%) provided any form of numerical indication of risk. Over half (52%) presented long lists of adverse effects in paragraphs of continuous text. Conclusions: Patient need is not being met in terms of the provision of usable information about the likelihood of adverse effects. Most patients receive no information, whereas some are given verbal descriptors, both of which lead to overestimation of the risk. Very few of the patient information leaflets assessed used currently described best practice, i.e. to present verbal descriptions alongside numerical information in the form of natural frequencies, e.g. ‘rare (affects less than 1 in 1000 people)’.
- 6 November 2007
- Published by Springer Nature
- p. 273-288
The Impact of Structuring the Interface as a Decision Tree in a Treatment Decision Support Tool
- 6 November 2007
- Published by Springer Nature
- p. 273-288
The Impact of Structuring the Interface as a Decision Tree in a Treatment Decision Support Tool